Desjardins Global Asset Management Inc. Seagen Inc. Transaction History

Desjardins Global Asset Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$191.51 - $216.16 $42,515 - $47,987	222 Added 43.27%	735 $155,000
Q2 2023 Aug 07, 2023	BUY	$187.64 - $206.25 $96,259 - $105,806	513 New	513 $98,000
Q2 2022 Aug 10, 2022	SELL	$108.81 - $179.33 $45,809 - $75,497	-421 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$119.61 - $157.85 $3,109 - $4,104	-26 Reduced 5.82%	421 $60,000
Q4 2021 Jan 31, 2022	BUY	$142.57 - $190.86 $63,728 - $85,314	447 New	447 $69,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Desjardins Global Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Desjardins Global Asset Management Inc. with notifications on news.